Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiyao Xiaoke Oral Liquid for erectile dysfunction in men with type 2 diabetes
ChiCTR-TRC-12003023Phase 4Completed
- Sponsor
- Zhu Xianyi Memorial Hospital
- Start
- Jan 2013
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Qiyao Xiaoke in erectile dysfunction (ED) (2 arms), sponsored by Zhu Xianyi Memorial Hospital. Primary endpoint: International Index of Erectile Function. Started Jan 2013; status: completed.
02
Drugs
Qiyao Xiaoke
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ChiCTR-TRC-12003023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003023.